Related Experiment Videos
Electrocardiograms in hypertensive subjects from a population random sample: basic characteristics and correlations
Summary
This study on hypertension screening found left ventricular hypertrophy (LVH) in 21.3% of males and 14.6% of females, and myocardial ischemia (ISC) in 5.7% of males and 18.1% of females.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- The World Health Organization (WHO) initiated a Community Control Programme of Hypertension in Italy.
- Hypertension screening is crucial for early detection and management of cardiovascular diseases.
- Electrocardiogram (ECG) is a key diagnostic tool for assessing cardiac abnormalities.
Purpose of the Study:
- To determine the prevalence of electrocardiographic abnormalities, specifically left ventricular hypertrophy (LVH) and myocardial ischemia (ISC), in a hypertensive population.
- To investigate the correlation of LVH and ISC with age and body mass index (BMI) in relation to sex.
Main Methods:
- A population-based screening of 5,856 individuals in Camposampiero, Italy, identified 1,190 hypertensives.
- Standard ECG tracings were recorded and interpreted using the 2nd version of the Minnesota Code (MC).
- Prevalence rates of MC items, LVH, and ISC were calculated and analyzed for correlations with age and BMI.
Main Results:
- Absolutely normal ECGs (MC item 1-0) were found in 41.1% of subjects; 23.3% had minor deviations (MC items 9-4).
- Prevalence of LVH was 21.3% in males and 14.6% in females; ISC prevalence was 5.7% in males and 18.1% in females.
- Significant positive correlations with age were observed for LVH and ISC in females, and for ISC in males. LVH showed a negative correlation with BMI in males.
Conclusions:
- The study highlights significant prevalence of LVH and ISC in a hypertensive Italian community.
- Age and BMI are important factors influencing cardiac abnormalities, with sex-specific correlations.
- ECG screening, as part of community programs, is valuable for identifying at-risk individuals for hypertension-related complications.